Publications produced with ESRs contribution

  1. Moustafa S. Ghanem, Fiammetta Monacelli and Alessio Nencioni.
    Advances in NAD-Lowering Agents for Cancer Treatment.
    Nutrients, 2021, 13(5), 1665. DOI:
  2. Francesca Arruga, Benjamin Baour Gyau, Andrea Iannello, Nicoletta Vitale, Tiziana Vaisitti and Silvia Deaglio.
    Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions.
    International Journal of Molecular Sciences, 2020 Mar; 21(5): 1825.DOI: 10.3390/ijms21051825.
  3. Francesca Arruga, Sara Serra, Nicoletta Vitale, Giulia Guerra, Andrea Papait, Benjamin Baffour Gyau, Francesco Tito, Dimitar Efremov, Tiziana Vaisitti, Silvia Deaglio.
    Targeting of the A2A adenosine receptor counteracts immunosuppression in vivo in a mouse model of chronic lymphocytic leukemia.
    Haematologica, Early view Apr 16, 2020. DOI: 10.3324/haematol.2019.242016.
  4. Pamela Becherini, Irene Caffa, Francesco Piacente, Patrizia Damonte, Valerio Vellone, Mario Passalacqua, Andrea Benzi, Tommaso Bonfiglio, Daniele Reverberi, Amr Khalifa, Moustafa Ghanem, Ana Guijarro, Luca Tagliafico, Marzia Sucameli, Angelica Persia, Fiammetta Monacelli, Michele Cea, Santina Bruzzone, Silvia Ravera, and Alessio Nencioni.
    SIRT6 enhances oxidative phosphorylation in breast cancer and promotes mammary tumorigenesis in the mouse.
    Cancer & Metabolism, 9, Article number: 6 (2021). DOI:

Publications produced by PIs

  1. Valentina Audrito, Vincenzo Gianluca Messana, Silvia Deaglio (2020).
    NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation.
    Front. Oncol., 19 March 2020. DOI:
  2. Tiziana Vaisitti, Francesca Arruga, Giulia Guerra, Silvia Deaglio.
    Ectonucleotidases in Blood Malignancies: A Tale of Surface Markers and Therapeutic Targets.
    Front. Immunol., 04 October 2019. DOI:
  3. Valentina Audrito, Antonella Managò, Federica Gaudino, Leonardo Sorci,Vincenzo Gianluca Messana, Nadia Raffaelli and Silvia Deaglio.
    NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer.
    Front. Immunol., 25 July 2019. DOI: